参考文献

参考文献

［1］Chang D K，Johns A L，Merrett N D，et al.Marginclearance and outcome in resectedpancreatic cancer［J］.J Clin Oncol，2009，27（17）：2855-2862.

［2］Court C M，Ankeny J S，Sho S，et al.Circulating tumor cells predict occult metastatic disease and prognosis in pancreatic cancer［J］.Ann Surg Oncol，2018，25（4）：1000-1008.

［3］Dhir M，Zenati M S，Hamad A，et al.FOLFIRINOX versus gemcitabine/nabpaclitaxel for neoadjuvant treatment of resectable and borderline resectable pancreatic head adenocarcinoma［J］.Ann Surg Oncol，2018，25（7）：1896-1903.

［4］Du F，Wang X，Lin H，et al.Pancreaticoduodenectomy with arterial approach of total mesenteric resection of the pancreas for pancreatic head cancer［J］.Gastroenterology Res，2019，12（5）：256-262.

［5］Ducreux M，Cuhna A S，Caramella C，et al.Cancer of the pancreas：ESMO clinical practice guidelines for diagnosis，treatment and followup［J］.Ann Oncol，2015，26（suppl 5）：v56-v68.

［6］Dumitrascu T，Martiniuc A，Brasoveanu V，et al.One hundred pancreatectomies with venous resection for pancreatic adenocarcinoma［J］.Chirurgia（Bucur），2018，113（3）：363-373.

［7］Egawa S，Takeda K，Fukuyama S，et al.Clinicopathological aspects of small pancreatic cancer［J］.Pancreas，2004，28（3）：235-240.

［8］Farnell M B，Pearson R K，Sarr M G，et al.A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma［J］.Surgery，2005，138（4）：618-628.

［9］Hamidian Jahromi A，Jafarimehr E，Dabbous H M，et al.Curative resection of pancreatic adenocarcinoma with major venous resection/repair is safe procedure but will not improve survival［J］.JOP，2014，15（5）：433-441.

［10］Han L，Chen W，Zhao Q.Prognostic value of circulating tumor cells in patients with pancreatic cancer：a meta-analysis［J］.Tumor Biol，2014，35（3）：2473-2480.

［11］Hank T，Hinz U，Tarantino I，et al.Validation of at least 1mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail［J］.Br J Surg，2018，105（9）：1171-1181.

［12］Hartwig W，Gluth A，Hinz U，et al.Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer［J］.Br J Surg，2016，103（12）：1683-1694.

［13］Huebner M，Kendrick M，Reid-Lombardo K M，et al.Number of lymph nodes evaluated：prognostic value in pancreatic adenocarcinoma［J］.J Gastrointest Surg，2012，16（5）：920-926.

［14］Ironside N，Barreto S G，Loveday B，et al.Meta-analysis of an artery-firstapproach versus standard pancreatoduodenectomy on perioperative outcomes and survival［J］.Br J Surg，2018，105（6）：628-636.

［15］Jang J Y，Kang M J，Heo J S，et al.A prospective randomized controlled study comparing outcomes of standard resection and extended resection，including dissection of the nerve plexus and various lymph nodes，in patients with pancreatic head cancer［J］.Ann Surg，2014，259（4）：656-664.

［16］Jang J Y，Kang M J，Heo J S，et al.A prospective randomized controlled study comparing outcomes of standard resection and extended resection，including dissection of the nerve plexus and various lymph nodes，in patients with pancreatic head cancer［J］.Ann Surg，2014，259（4）：656-664.

［17］Jung K W，Kim M H，Lee T Y，et al.Clinicopathological aspects of 542 cases of pancreatic cancer：a special emphasis on small pancreatic cancer［J］.J Korean Med Sci，2007，22（Suppl）：S79-85.

［18］Konstantinidis I T，Warshaw A L，Allen J N，et al.Pancreatic ductal adenocarcinoma：is there a survival difference for R1 resections versus locally advanced unresectable tumors？What is a“true”R0 resection［J］.Ann Surg，2013，257（4）：731-736.(https://www.daowen.com)

［19］Marmor S，Burke E E，Portschy P R，et al.Lymph nodeevaluation for treatment of adenocarcinoma of the pancreas［J］.Surg Oncol，2015，24（3）：284-291.

［20］Mokdad A A，Minter R M，Zhu H，et al.Neoadjuvant therapy followed by resection versus upfront resection for resectable pancreatic cancer：a propensity score matched analysis［J］.J Clin Oncol，2017，35（5）：515-522.

［21］Nanno Y，Toyama H，Otani K，et al.Microscopicvenousinvasion in patients with pancreatic neuroendocrine tumor as a potential predictor of postoperativerecurrence［J］.Pancreatology，2016，16（5）：882-887.

［22］Panaro F，Kellil T，Vendrell J，et al.Microvascular invasion is a major prognostic factor after pancreatico-duodenectomy for adenocarcinoma［J］.J Surg Oncol，2019，120（3）：483-493.

［23］Pedrazzoli S，DiCarlo V，Dionigi R，et al.Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas：a multicenter，prospective，randomized study.Lymphadenectomy Study Group［J］.Ann Surg，1998，228（4）：508-517.

［24］Rawla P，Sunkara T，Gaduputi V.Epidemiology of pancreatic cancer：global trends，etiology and risk factors［J］.World J Oncol，2019，10（1）：10-27.

［25］Sabater L，Cugat E，Serrablo A，et al.Does the artery-first approach improve the rate of R0 resection in pancreatoduodenectomy：a multicenter，randomized，controlled trial［J］.Ann Surg，2019，270（5）：738-746.

［26］Sanli O，Zorba O U，Erdem S，et al.Microscopicvenousinvasion is associated with disease free and cancer free survival in renal cell carcinoma［J］.Minerva Urol Nefrol，2010，62（4）：347-353.

［27］Sgroi M D，Narayan R R，Lane J S，et al.Vascular reconstruction plays an important role in the treatment of pancreatic adenocarcinoma［J］.J Vasc Surg，2015，61（2）：475-480.

［28］Slidell M B，Chang D C，Cameron J L，et al.Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma：a large，population-based analysis［J］.Ann Surg Oncol，2008，15（1）：165-174.

［29］Strobel O，Hank T，Hinz U，et al.Pancreatic cancer surgery：the new R-status counts［J］.Ann Surg，2017，265（3）：565-573.

［30］Tol J A，Gouma D J，Bassiet C，et al.Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma：a consensus statement by the International Study Group on Pancreatic Surgery（ISGPS）［J］.Surgery，2014，156（3）：591-600.

［31］Tzeng C W D，Cao H S T，Lee J E，et al.Treatment sequencing for resectable pancreatic cancer：influence of early metastases and surgical complications on multimodality therapy completion and survival［J］.J Gastrointest Surg，2014，18（1）：16-24.

［32］Wagner M，Redaelli C，Lietz M，et al.Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma［J］.Br J Surg，2004，91（5）：586-594.

［33］Xu J，Tian X，Chen Y，et al.Total mesopancreas excision for the treatment of pancreatic head cancer［J］.J Cancer，2017，8（17）：3575-3584.

［34］Yamada M，Sugiura T，Okamura Y，et al.Microscopic venous invasion in pancreatic cancer［J］.Ann Surg Oncol，2018，25（4）：1043-1051.

［35］Zhang X P，Zhou T F，Cheng S Q，et al.Association of preoperative hypercoagulability with poor prognosis in hepatocellular carcinoma patients with microvascular invasion after liver resection：a multicenter study［J］.Ann Surg Oncol，2019，26（12）：4117-4125.